Phosphorylation of protocadherin proteins by the receptor tyrosine kinase Ret
The clustered protocadherins (Pcdhs) are a large family of cadherin-like transmembrane proteins expressed in the nervous system. Stochastic expression of Pcdh genes and alternative splicing of their pre-mRNAs have the potential to generate enormous protein diversity at the cell surface of neurons. A...
Saved in:
Published in | Proceedings of the National Academy of Sciences - PNAS Vol. 107; no. 31; pp. 13894 - 13899 |
---|---|
Main Authors | , , , , |
Format | Journal Article |
Language | English |
Published |
United States
National Academy of Sciences
03.08.2010
National Acad Sciences |
Series | From the Cover |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | The clustered protocadherins (Pcdhs) are a large family of cadherin-like transmembrane proteins expressed in the nervous system. Stochastic expression of Pcdh genes and alternative splicing of their pre-mRNAs have the potential to generate enormous protein diversity at the cell surface of neurons. At present, the regulation and function of Pcdh proteins are largely unknown. Here, we show that Pcdhs form a heteromeric signaling complex(es), consisting of multiple Pcdh isoforms, receptor tyrosine kinases, phosphatases, and cell adhesion molecules. In particular, we find that the receptor tyrosine kinase rearranged during transformation (Ret) binds to Pcdhs in differentiated neuroblastoma cells and is required for stabilization and differentiation-induced phosphorylation of Pcdh proteins. In addition, the Ret ligand glial cell line-derived neurotrophic factor induces phosphorylation of Pcdhγ in motor neurons and phosphorylation of Pcdhα and Pcdhγ in sympathetic neurons. Conversely, Pcdh proteins are also required for the stabilization of activated Ret in neuroblastoma cells and sympathetic ganglia. Thus, Pcdhs and Ret are functional components of a phosphorylation-dependent signaling complex. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Article-2 ObjectType-Feature-1 Author contributions: S.S.S., S.M.B., and T.M. designed research; S.S.S., B.A.B., and S.M.B. performed research; G.R.P. contributed new reagents/analytic tools; S.S.S., B.A.B., and T.M. analyzed data; and S.S.S., S.M.B., and T.M. wrote the paper. 1Present address: Agios Pharmaceuticals, Cambridge, MA 02139. Contributed by Tom Maniatis, June 1, 2010 (sent for review February 2, 2010) 2B.A.B. and S.M.B. contributed equally to this work. 3Present address: The Rowland Institute at Harvard University, Cambridge, MA 02142. 4Present address: Department of Biochemistry and Molecular Biophysics, Columbia University College of Physicians and Surgeons, New York, NY 10032. |
ISSN: | 0027-8424 1091-6490 |
DOI: | 10.1073/pnas.1007182107 |